IMS Health Inc.

Former Chief Executive Officer of Reliant Pharmaceuticals, Inc. Former President, U.S. Human Health, Merck & Co., Inc. Dr. Sheares served as Chief Executive Officer of Reliant Pharmaceuticals, Inc., a pharmaceutical company with integrated sales, marketing and development expertise that marketed a portfolio of branded cardiovascular pharmaceutical products, from January 2007 through its acquisition by GlaxoSmithKline plc in December 2007. Prior to joining Reliant, Dr. Sheares served as President of U.S. Human Health, Merck & Co. from March of 2001 until July 2006. Prior to that time, he served as Vice President, Hospital Marketing and Sales for Merck’s U.S. Human Health business. Dr. Sheares joined Merck in 1987 as a research fellow in the Merck Research Laboratories and held a wide range of positions within Merck, in business development, sales, and marketing, before becoming Vice President in 1996. He is also a director of The Progressive Corporation and Covance Inc. Director since 2004 Age: 52

Mr. Lockhart is Chairman of Diamond Castle's Financial Institutions investment practice. Prior to joining Diamond Castle in 2005, Mr. Lockhart was a Venture Partner at Oak Investment Partners focusing on financial services technology opportunities. Previously, he served in a variety of senior executive roles at various organizations, including President and Chief Executive Officer of MasterCard International, Chief Executive Officer of Midland Bank plc, President of the Global Retail Bank of Bank of America and President of Consumer Services at AT&T. Mr. Lockhart is Chairman of PRC, LLC, and a Director of Checksmart Financial Company, IMS Health Inc. (NYSE: RX), RadioShack Corp. (NYSE: RSH) and Asset Acceptance Corp. (NASDAQ: AACC). He is a former Director of RJR Nabisco Holdings (NYSE: RJR), First Republic Bank (NYSE: FRC), LendingTree, Inc. (NASDAQ: TREE) and several other companies. He has served as President of the Board of Managers of the University of Virginia and Chairman of The Darden School Foundation Board of Trustees. He holds a B.S., with Honors, from the University of Virginia and an M.B.A. from The Darden School at the University of Virginia.

Michael Fitzgerald became Chief Technology Officer for DecisionOne in January of 2007 after serving the company as Chief Information Officer from July 2005 through December 2006. In this role, he is responsible for preparing new technologies and services for transition to DecisionOne's core delivery centers and for maintaining second line technical support. His core areas of responsibility are technology development and adoption, national technical support, professional services, and strategic business development support. Mr. Fitzgerald has nearly 25 years of information technology experience, having run IT organizations for Global 2000 companies as well as at smaller software companies. He is a highly accomplished IT professional with senior leadership experience in world-class organizations such as IMS Health, CSC Consulting, and a leading global pharmaceutical company, and has extensive experience in start-up organizations as well.

Adel Al-Saleh is president, Europe, Middle East and Africa, responsible for IMS operations in more than 50 countries. Mr. Al-Saleh was named to this position in August 2007, having previously served as IMS’s senior vice president, Sales and Major Countries, EMEA. He joined the company following a 19-year career at IBM, where most recently he was vice president, Sales for IBM Northeast Europe, responsible for business across all industries and brands in the region. Starting at IBM as a development engineer, Mr. Al-Saleh held progressively more responsible positions in product development, global brand management and business management. In 1997, Mr. Al-Saleh assumed responsibility for IBM’s Personal Computer business in the European Emerging Markets, covering Central and Eastern Europe, the Middle East and Africa. He was appointed two years later to the role of vice president of Sales for IBM’s Personal Computer business across Europe, the Middle East and Africa. In 2001, Mr. Al-Saleh became general manager, Global Wireless Business, with responsibility for the business, applications and services of IBM’s wireless and mobile initiatives around the world. Named vice president, Communications Sector, IBM Americas in 2003, he led IBM’s business in the Telecommunications, Energy and Utilities, Media and Entertainment industries in the U.S., Canada and Latin America. A graduate of Boston University, Mr. Al-Saleh earned a B.S. in Electrical Engineering and an M.B.A. from Florida Atlantic University.

William J. Nelligan is president, Americas, responsible for IMS operations in the U.S., Canada and Latin America. He was named to the position in November 2006, following two years as head of the IMS Americas Strategic Partners group. In that role, he was responsible for business development activities for a number of acquisitions and alliances, drove compliance with third-party access agreements and built relationships with key data supply partners. With more than a decade of experience in the healthcare information marketplace, Mr. Nelligan joined IMS in 2000 and has held several key management positions, including senior vice president, Emerging Markets, and president, IMS Asia Pacific, where he managed operations in 18 countries and significantly expanded IMS's business in that region. Before joining IMS, Nelligan served as vice president of Wind Corporation, a global sourcing service provider in the hardware component marketplace and, prior to that, was a director of international business for Goodway Technologies, an industrial products manufacturer. From 1989 to 1997, he held various sales and marketing and international business development positions with Medical Economics, Inc. a member of the Thomson Healthcare Information Group, an operating unit of Thomson Corporation. Nelligan holds a B.S. degree in finance from Ithaca College, Ithaca, NY.

Leslye G. Katz is senior vice president and chief financial officer of IMS, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. She leads IMS's worldwide finance organization, with responsibility for finance and accounting, treasury, internal audit and investor relations. Before assuming her current position, Ms. Katz served as IMS’s vice president and controller from 2001 to 2007. In that role, she built a strong finance and accounting team and led the company’s SEC reporting and financial planning and analysis activities. Previously, she was vice president and chief financial officer of American Lawyer Media, Inc., a legal journalism and information company, for three years. From 1996 to 1998, Ms. Katz was vice president and treasurer of IMS’s predecessor company, Cognizant Corporation. In 1980, she joined The Dun & Bradstreet Corporation, where she held a number of senior financial management posts, including senior vice president and chief financial officer of Reuben H. Donnelley, a D&B division. Ms. Katz holds a B.A. degree from Brown University and an MBA from the Wharton School of the University of Pennsylvania.

Karla Packer is senior vice president, Human Resources for IMS, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries. She is responsible for all human resources functions, including talent acquisition, performance management and career development for IMS worldwide. Before joining IMS in 2007, Ms. Packer was vice president, Human Resources for IAC/InterActiveCorp, a $6 billion e-commerce enterprise. IAC includes such brands as Ticketmaster, the Home Shopping Network, Lending Tree and Ask.com. In this role, Ms. Packer was responsible for leading the human resources organization globally. Prior to her role at IAC, Ms. Packer was chief administrative officer at Spencer Trask and Co., a venture capital firm, and vice president, Global Human Resources for Avon Products. From 1980 to 1994, she held various roles at IBM, in the area of human resources, information systems, sales and marketing. Ms. Packer holds a B.S. degree in mathematics from Tufts University.

Jack Walsh is senior vice president, Strategy and Business Development, with responsibility for the company's strategic planning process and for identifying and assessing acquisitions, alliances and new business opportunities. Previously, Walsh served as IMS's vice president of Corporate Development as well as vice president and Treasurer, and vice president of Investor Relations. He joined IMS's predecessor company, Cognizant Corporation, as director of Financial Planning in 1997. Walsh has an extensive background in mergers and acquisitions, business and strategic planning and in evaluating international business opportunities. Previously, he worked at MCI Communications Corporation, where he held positions of increasing executive responsibility in finance during his 12-year tenure. He began his career in Finance with Ford Motor Corporation in 1978, moving to Ryder Systems Corporation in 1981. Walsh received a B.B.A. degree from the University of Notre Dame and an M.B.A. from the University of Chicago.

Randolph Frankel is currently Vice President, Public Affairs and Government Relations at IMS Health. He has had extensive experience in the areas of pharmaceutical marketing and services, pharmaceutical benefits management (PBM's), Disease Management, eHealth, and healthcare information services. Under his leadership, IMS Health is developing with the CMA and the AMA, an information service for physicians, utilizing evidence-based information in combination with medical education as a tool for self-evaluation and quality improvement.

Deborah Kobewka is general manager, Asia Pacific, responsible for IMS operations in 16 countries. She was named to the position in October 2008. In more than two decades of service with IMS, Ms. Kobewka has established a strong track record of leadership in both regional and global roles. Previously, she served as general manager, Consumer Health, where she drove the development of the company’s consumer health initiatives worldwide, providing clients with deeper insights and analytics into healthcare dynamics. Prior to that, Ms. Kobewka led IMS’s Portfolio Optimization business in Europe from 2001 to 2006, responsible for building and launching services to help pharmaceutical clients manage and develop their product portfolios. In that role, she was instrumental in developing strategy and overseeing the launch of next-generation market measurement offerings and consulting capabilities. Joining IMS in 1987, Ms. Kobewka also has managed IMS’s Publications business to provide thought leadership to clients, and has held leadership positions in Client Services, Sales and Marketing. Ms. Kobewka holds a B.S. degree in biochemistry from the University of Sussex, United Kingdom.

Raymond Hill is IMS’s general manager, Consulting and Services, responsible for the strategic development and management of these capabilities on a global basis. He leads the company’s team of consultants and services professionals who provide integrated, evidence-based solutions that enable pharmaceutical clients and other healthcare stakeholders to make informed business decisions. Mr. Hill joined IMS in 2003 with initial responsibility for Cambridge Pharma Consultancy, a company IMS acquired in 2001. In 2004, he was named vice president, Consulting and Services for Asia Pacific and Japan. In this role, he was instrumental in expanding IMS’s Consulting and Services business and strengthening the organization’s leadership capabilities to better serve the growing needs of clients in the region. He was named general manager of IMS consulting in 2006 and assumed worldwide responsibility for services in 2008. Before joining IMS, Mr. Hill was global head of A.T. Kearney’s Pharmaceuticals and Health Care Practice, and was the co-organizer and founder of the Health Care Future Forces Leadership Roundtable, a group of senior healthcare executives focused on assessing the impact of major changes on the healthcare value chain. Mr. Hill was named one of the Top 25 Consultants of 2007 by Consulting Magazine, and PharmaVOICE selected him as “most admired” on the 2007 PharmaVOICE 100 list. His work on the pharmaceutical industry has been covered in various publications, most recently by The Economist, Business Week, The Financial Times and Pharmaceutical Executive. Mr. Hill holds a B.S. degree from Cornell University, and an M.E.M. from Duke University.

David brings over 15 years of sales, training, sales management, marketing, and business development experience within the pharmaceutical and biotech business worlds. David started out his experience in the pharmaceutical industry as a sales representative for Glaxo Pharmaceuticals. Moving on to Syntex Laboratories where he had responsibility for hospital and managed care business. His time at Syntex also included work in sales training and managed care marketing. With the merger of Syntex and Roche, David joined in as a District Manager for a specialized sales division. Heading up a division of 17 salespersons responsible for over $50 Million in annual sales. David went on the successfully manage a sales team for Agouron Pharmaceuticals where his knowledge and skills were focused in the BioTech industry. Acting as a Regional Sales Manager, his group was responsible for the sales of over $120 Million of the flagship product during his tenure at the company. David is currently with IMS Health as a Senior Account Manager working with BioTech organizations within California and Arizona. He is responsible for bringing in new business within newly created and established BioTech organizations. He is strongly networked into the industry and very knowledgeable on the topic of pharmaceutical/biotech companies. In addition, David stays very networked to many organizations working with and around the Biotech industry. His experiences have lead to a full understanding of the mobile user and it's opportunities for Tailwind Solutions, Inc.

Jack Walsh is senior vice president, Strategy and Business Development, with responsibility for the company's strategic planning process and for identifying and assessing acquisitions, alliances and new business opportunities. Previously, Mr. Walsh served as IMS’s vice president of Corporate Development as well as vice president and Treasurer, and vice president of Investor Relations. He joined IMS’s predecessor company, Cognizant Corporation, as director of Financial Planning in 1997. Mr. Walsh has an extensive background in mergers and acquisitions, business and strategic planning and in evaluating international business opportunities. Previously, he worked at MCI Communications Corporation, where he held positions of increasing executive responsibility in finance during his 12-year tenure. He began his career in Finance with Ford Motor Corporation in 1978, moving to Ryder Systems Corporation in 1981. Mr. Walsh received a B.B.A. degree from the University of Notre Dame and an M.B.A. from the University of Chicago.

Mr. Summe joined LiveVox in October 1999. Before joining the Company, Mr. Summe served as the Vice President of Business Development and Product Management for Physicians' Online (POL), the leading online service for physicians with over 200,000 physician members. His accomplishments include developing several market leading physician communication products (Fastview market research and MyDoctor.com physician web sites - sold to Aventis Pharmaceuticals for $4.5 million) and creating alliances with Merck-Medco and IMS Health. Mr. Summe was instrumental in selling POL to Mediconsult - now part of WebMD (Nasdaq: HLTH) for $200 million. Prior to joining POL, Mr. Summe held Marketing, Product Development & Business Development positions at Merck-Medco. His accomplishments include physician and patient communication programs for Pfizer and Merck, which enrolled over 10,000 physicians, 3.5 million patients and generated $50 million in annual revenues. Prior to Merck-Medco, Mr. Summe was a Systems Engineer at EDS. Mr. Summe holds an M.B.A. with honors from Columbia University and a B.A. in Physics from Xavier University.

Michael is responsible for Finance, Legal, HR, IT, Logistics, Facilities and Administration. His key skills include strategic and operational development in conjunction with EMEA and US Leadership Teams, recruiting and building a robust finance and administration function to assist with growth, and enabling the sales teams to close transactions for revenue under US GAAP. Michael has twenty years of experience in Finance and has held senior finance and management positions in the last ten years with high growth US software and database companies such as Walsh International, Pharmaceutical Marketing Services, IMS Health and Genesys Telecommunications. Michael is a graduate from Wolverhampton University, a Fellow Chartered Accountant and an Associate of the UK Corporate Treasurers.

Murray L. Aitken is senior vice president, Healthcare Insight, responsible for leading IMS’s thought leadership initiatives worldwide. He joined IMS in July 2001 and was initially responsible for the growth and development of the company’s consulting and services businesses. Named to his current role in August 2007, Mr. Aitken previously was senior vice president, Corporate Strategy. Mr. Aitken speaks regularly on the challenges facing the global pharmaceutical industry and the likely prospects for growth over the next five years. He is regularly quoted in major trade and general media, including The Financial Times, Fortune, BusinessWeek, Associated Press and Reuters, and in 2005 was named by PharmaVOICE as one of the 100 most inspiring business leaders. Mr. Aitken chairs the Editorial Board of IMS Intelligence.360, an annual publication focused on the dynamics of the global pharmaceutical market. He also is editor of HealthIQ, a publication focused on the value of information in advancing evidence-based healthcare. Prior to joining IMS, Mr. Aitken had a 14-year career with McKinsey & Company. He was a leader in the Pharmaceutical and Medical Products practice from 1997 to 2001. During this time, he served major pharmaceutical companies on a range of strategic and organizational issues for senior R&D and commercial management. He was among McKinsey’s thought leaders on issues related to pharmaceutical licensing and direct-to-consumer marketing. Earlier in his career with McKinsey, he helped establish and develop the company's Seoul, Korea office serving the senior management of major Korean conglomerates. Mr. Aitken received an M.B.A. degree with distinction from Harvard University in 1987. He also holds a Master of Commerce degree from the University of Auckland in New Zealand.

Richard joined IMS Health straight from university in 1992. While initially intending to stay only for a couple of years, found himself there until the end of 2005. His time at IMS saw him move from internal software development projects (Dataview anyone?), to sales and service roles in many market sectors, including consumer health, ethical pharmaceuticals, biotechnology and the chemical industry. Managing the accounts of companies across Europe and The USA served to further broaden his perspectives on the international pharmaceutical industry. Responsible for the IMS Publications portfolio and latterly moving into co-ordinating pan-European sales force effectiveness projects, Richard has broad experience of what pharmaceutical companies look for in the agencies they work with, and he has sought to bring that experience to bear since joining Activity Benchmarking in 2006. With a young family, Richard has no shortage of demands on his time away from the office, and wouldn't have it any other way! A keen but unaccomplished golfer, he also follows the roller-coaster fortunes of his beloved Leeds United.

Robert H. Steinfeld is senior vice president, general counsel and corporate secretary of IMS. Named to that position in December 2000, Mr. Steinfeld’s responsibilities as general counsel include global legal and commercial affairs, government and regulatory relations and corporate compliance. Mr. Steinfeld joined IMS' predecessor company, Cognizant Corporation, in 1997 as director of Taxes. When IMS was spun off from Cognizant in 1998, he was promoted to vice president-Taxes with the new company. Prior to his current assignment, he served as IMS' senior vice president-Tax & Corporate Development. He played a key role in the structuring and implementation of the IMS-Gartner Group spin-off and, most recently, in the Synavant spin-off. Mr. Steinfeld began his business career as a lawyer in New York City. From 1987 to 1991, he was a partner and chairman of the Tax Department at the law firm of Webster & Sheffield, where he represented a variety of US and foreign multinationals. Before joining Cognizant, Mr. Steinfeld held a variety of senior management positions, including vice president-Taxation at Ultramar Corporation, a multinational petroleum refining and marketing company, and vice president-Taxes at GAF Corporation, a privately held, diversified holding company. While at GAF, he also served as vice president-Taxes of GAF’s publicly traded subsidiary, International Specialty Products, Inc., a multinational chemical firm. Mr. Steinfeld earned a BA from Columbia University in 1975, a JD from the Columbia University School of Law in 1978, and an LLM in Taxation from the New York University School of Law in 1981.